Home » Newsletters » BioWorld Science

BioWorld Science

July 25, 2012

View Archived Issues

Researchers at Leo Pharma patent novel ingenol compounds

Candidate Syntaxin drug for acromegaly has new mode of action

New NK3 receptor antagonists presented by Roche

New antifungals prepared at Janssen Pharmaceutica

Eutropics Pharmaceuticals discloses novel Mcl-1/Bcl-XL inhibitors

New IGF-I receptor inhibitors reported by Boehringer Ingelheim

Janssen Pharmaceutica divulges new BACE1 inhibitors

Belgian-Dutch collaboration yields candidate biomarker for use in kidney transplant recipients

Novel OGA inhibitors designed

BioCryst reports on two phase II trials of BCX-4208

Data presented on sustained-release plug for glaucoma

Recruitment begins in phase II NKTR-181 trial

First preclinical candidate drug selected in osteoarthritis alliance

Merck & Co. provides update on anti-HIV drug development

Dynavax submits MAA for Heplisav hepatitis B vaccine

Sarepta drug shows clinical benefit in Duchenne muscular dystrophy

Ongoing conference features new data on anti-HIV/HSV combination gel

Pfizer reports topline results from first of four phase III bapineuzumab studies

First patient treated in study of subcutaneous Debio-8206

Biofrontera holds meeting with FDA regarding planned application for Ameluz

FDA grants priority review to enzalutamide NDA

FDA issues safety communication regarding Ampyra

Anticancer drug shows promise to treat Alzheimer's disease

Psyadon halts ecopipam study based on promising interim results

SRI receives NIAID grant for development of bioadhesive gel

European Commission approves combination tablet for type 2 diabetes

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...